(B) Purification & Filtration
-
Eagle Pure Water Systems, Inc. (December 2012), based in Pennsylvania, Eagle Pure Water Systems installs, services and provides ion exchange resin regeneration services for customers in medical, laboratory and research industries. Through this acquisition Mar Cor Purification will further expand its Philadelphia market presence and better meet the needs of its national customers.
- Gambro Medical Water Systems (US) (October 2010), based in the Denver area, the Gambro Medical Water Business includes a customer base of over 1,200 dialysis clinics and hospitals across the United States and two key product lines for producing medical-grade water. The addition of Gambro’s CWP and WRO product lines, with their ability to provide heat disinfection, complements Mar Cor’s product portfolio and leadership position in medical water systems. These product lines will advance Mar Cor’s strategy to reduce the costs of producing medical grade water in the professional healthcare setting and in the home.
- Purity Water Company of San Antonio, Inc (June 2010), based in the San Antonio area, Purity Water provides water treatment equipment and services for laboratory, industrial, medical, pharmaceutical and semiconductor customers in Texas and neighboring states. This strategic Texas presence adds to Mar Cor’s leadership position in medical water. We can serve better our national customers and expand our business into commercial and industrial segments. Purity’s ion exchange plant is the seventh Mar Cor location in North America providing resin exchange services to the customer base.
- G.E.M. Water Systems (August 2009), based in the Los Angeles area, designs, builds, installs and services high quality water systems for dialysis clinics in the Western US. The addition will allow our Mar Cor Purification division to service better its national customers and further expand its West Coast presence for all products and services.
Dialysis Services, Inc. (August 2007), based in Springfield, TN, designs, installs and services high quality water and bicarbonate systems for use in dialysis clinics, hospitals and university settings. This service location addition furthers our Mar Cor Purification division’s strategy of providing local, high-quality, responsive service to our customers in the Tennessee Valley.
- GE Water & Process Technologies’ Dialysis Business (March 2007). Cantel’s Mar Cor Purification division acquired the #1 player in medical water equipment and consumables. GE’s business, formerly a part of GE Osmonics, had approximately 1,800 installations in North America with revenues of approximately $20 million. The acquisition expands Mar Cor’s water treatment division by 50%, thereby increasing the importance of water purification in Cantel’s infection prevention and control portfolio. By adding this entrenched installed base of customers, Mar Cor was able to solidify their position as the leading provider in dialysis water.
- Fluid Solutions, Inc. (May 2006). Cantel expanded its infection prevention and control business in water purification by purchasing certain assets of Fluid Solutions, Inc., a privately held high purity water systems manufacturer and service company based in Lowell, Massachusetts. We have integrated Fluid Solutions into Cantel’s Water Purification and Filtration segment (Mar Cor). This acquisition expands our customer base in the biotech, pharmaceutical, research, hospital, and semiconductor markets as well as our sales presence and resin regeneration capability in the New England area.
- Water Treatment Entry Strategy: Biolab & Mar Cor Services (August 2003 [Two acquisitions]). Cantel embarked on the development of a new leg of our business via the simultaneous acquisitions of The Biolab Group (Toronto & Montreal, Canada) and Mar Cor Services (Skippack, PA). With exceptional engineering and manufacturing capabilities, Biolab is now our primary water treatment equipment supplier. Cantel is leveraging Biolab's advanced equipment into Mar Cor's service and distribution network throughout the eastern half of the United States. Moreover, Biolab and Mar Cor leverage existing Minntech filters and disinfectant product lines. These companies further reinforce our commitment and strength in dialysis, while simultaneously affording us with new opportunities in the pharmaceutical and biotechnology markets.
|
